Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors

Considering the unrecognised physio-pathological role of human carbonic anhydrase III (hCA III), a structure-based drug design was set up to identify the first-in-class potent and selective inhibitors of this neglected isoform. hCA III targeting was planned considering a unique feature of its active...

Description complète

Détails bibliographiques

Auteurs principaux:	Simone Giovannuzzi, Alessandro Bonardi, Paola Gratteri, Alessio Nocentini, Claudiu T. Supuran
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2023-12-01
Collection:	Journal of Enzyme Inhibition and Medicinal Chemistry
Sujets:	Drug design metalloenzyme inhibition click chemistry hCA III molecular dynamics
Accès en ligne:	https://www.tandfonline.com/doi/10.1080/14756366.2023.2202360
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!